Genetic alterations and their clinical implications in DLBCL
Repository Usage Stats
Published Version (Please cite this version)10.1038/s41571-019-0225-1
Publication InfoYoung, Ken; Miao, Yi; Medeiros, L Jeffrey; Li, Yong; & Li, Jianyong (2019). Genetic alterations and their clinical implications in DLBCL. Nature Reviews Clinical Oncology, 16(10). pp. 634-652. 10.1038/s41571-019-0225-1. Retrieved from https://hdl.handle.net/10161/19338.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Instructor in the Department of Pathology
I am a clinically-oriented diagnostic physician with clinical expertise in the pathologic diagnosis of hematologic cancers including tumors of the bone marrow, lymphoid tissue, spleen and pre-malignant hematologic conditions. Another area of interest is blood cancer classification with molecular and genetic profiling. In my research program, we focus on molecular mechanisms of tumor progression, cell-of-origin, biomarkers, and novel therapeutic strategies in lymphoma, myeloma and leukemia. In